As the number of RSV infections rises, two recent studies found that protecting babies against the disease prevented ...

Respiratory syncytial virus (RSV) is a common virus that affects the nose, throat, and lungs. For most healthy adults and ...

In 2023, the FDA and CDC's Advisory Committee on Immunization Practices (ACIP) voted in favor of recommending the monoclonal ...

As respiratory illness runs high in Iowa, Olympic gold medalist Shawn Johnson East is urging parents to watch for RSV ...

Scientists have uncovered strong evidence that infection with RSV in the first months of life can significantly raise the ...

Infants who receive nirsevimab may have a lower risk for hospitalisation for RSV-related lower respiratory tract infection ...

How effective is nirsevimab at preventing respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD), ...

Globally, RSV causes millions of respiratory infections each year and is responsible for a large proportion of ...

Respiratory syncytial virus (RSV) remains a leading cause of severe lower respiratory infections among infants, particularly ...

We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...

As families and friends gather for holiday celebrations, respiratory syncytial virus (RSV), also makes its return.

Maternal vaccines are safe, effective, and one of the simplest ways to give your child the healthiest start possible. To ...